PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA
Clinical trial NCT03006432 · COMPLETED
Trial details
- NCT number
- NCT03006432
- Sponsor
- Federation Francophone de Cancerologie Digestive
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-19
- Primary completion
- 2025-02-27
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.